M-EZETIMIBE TABLET

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

EZETIMIBE

Beszerezhető a:

MANTRA PHARMA INC

ATC-kód:

C10AX09

INN (nemzetközi neve):

EZETIMIBE

Adagolás:

10MG

Gyógyszerészeti forma:

TABLET

Összetétel:

EZETIMIBE 10MG

Az alkalmazás módja:

ORAL

db csomag:

100/500

Recept típusa:

Prescription

Terápiás terület:

CHOLESTEROL ABSORPTION INHIBITORS

Termék összefoglaló:

Active ingredient group (AIG) number: 0149164001; AHFS:

Engedélyezési státusz:

APPROVED

Engedély dátuma:

2017-08-18

Termékjellemzők

Page
1
of
30
PRODUCT MONOGRAPH
PR
M-EZETIMIBE
Ezetimibe Tablets, USP
10 mg
Cholesterol Absorption Inhibitor
Mantra Pharma Inc.,
1000 du Lux, suite 201
Brossard, Quebec
J4Y 0E3
Control # 275104
Date
of
Revision:
MAY
30, 2023
Page
2
of
30
TABLE OF CONTENT
Table of Content
.....................................................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................3
SUMMARY PRODUCT INFORMATION
...........................................................................................3
INDICATIONS AND CLINICAL USE
............................................................................................3
CONTRAINDICATIONS
.................................................................................................................4
WARNINGS AND PRECAUTIONS
................................................................................................4
ADVERSE REACTIONS
.................................................................................................................7
DRUG INTERACTIONS
................................................................................................................11
DOSAGE AND ADMINISTRATION
............................................................................................13
OVERDOSAGE
..............................................................................................................................14
ACTION AND CLINICAL PHARMACOLOGY
..........................................................................14
STORAGE AND STABILITY
........................................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
...........................................................16
PART II: SCIENTIFIC INFORMATION
............................................................................................17
PHARMACEUTICAL INFORMATION
.......